Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease

摘要

class="kwd-title">Abbreviations: MR, magnetic resonance; LIF, Liver Inflammation and Fibrosis score; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; ELF, Extended Liver Fibrosis; MRE, magnetic resonance elastography; ¹H-MRS, proton magnetic resonance spectroscopy; HCC, hepatocellular carcinoma; cT1, iron corrected T1; LMS, LiverMultiScan class="kwd-title">Keywords: T1 mapping, Iron corrected T1, LIF score, LiverMultiScan class="head no_bottom_margin" id="idm140667272716864title">AbstractBackground & AimsMultiparametric magnetic resonance (MR) imaging has been demonstrated to quantify hepatic fibrosis, iron, and steatosis. The aim of this study was to determine if MR can be used to predict negative clinical outcomes in liver disease patients.